Yiling Pharma Release: Company Invests $20 Million in Israel's HealthWatch

January 17, 2017 -- Shijiazhuang Yiling Pharma invested $20 million in HealthWatch, an Israeli company that developed a T-shirt-like wearable monitoring device. Sensors are woven into the fabric and communicate with a pickup device for real-time monitoring. $15 million of the total will be invested into HealthWatch, giving Yiling a 23% stake in the company, and $5 million will pay for China rights to the wearable device. Yiling is known primarily as a TCM company.

Back to news